Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 1, 2009, Pages 30-33

  Shoaib, Tabassum ^a,b   Khan, Saba ^a   Javed, Iffat ^a   Bhutta, Shereen Z ^a  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^b NONE   (Pakistan)

Author keywords

Loading dose; Magnesium sulphate; Pre eclampsia; Pritchard regimen

Indexed keywords

MAGNESIUM SULFATE;

ADULT; ARTICLE; BOLUS INJECTION; CESAREAN SECTION; CHEMOPROPHYLAXIS; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CONVULSION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; ECLAMPSIA; FEMALE; FISHER EXACT TEST; FLUSHING; HEALTH CARE COST; HEAT; HUMAN; INJECTION SITE IRRITATION; LIVE BIRTH; LOADING DRUG DOSE; NAUSEA AND VOMITING; PAKISTAN; PATIENT MONITORING; PERINATAL CARE; PREECLAMPSIA; QUASI EXPERIMENTAL STUDY; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE;

ADULT; ANTICONVULSANTS; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GESTATIONAL AGE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MAGNESIUM SULFATE; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63049088140     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The Magpie trial. Collaboration Group. Do women with pre-eclampsia and their babies benefit from magnesium sulphate? The magpie trial: a randomized placebo controlled trial. Lancet 2002; 359: 1877-90.
2. The National Institute for Clinical Excellence, The Scottish Executive Health Department. The Department of Health, Social Services and Public Safety, Northern Ireland. Why mothers die 1997-1999. The fifth report of confidential enquiries into maternal death in U.K. London; RCOG Press, 2001.
3. Sibai BM. Magnesium sulphate prophylaxis in pre-eclampsia: lessons learnt from recent trials. Am J Obstet Gynecol 2004; 190: 1520-6.
4. Sibai BM. Magnesium sulphate is the ideal anticonvulsant in pre-eclampsia. Am J Obstet Gynecol 1990; 162: 1141-5.
5. Talatnaz, Lubna Hasan, Mehrunnisa. Eclampsia-management and outcome with magnesium sulpahate as the anticonvulsant. J Coll Physicians Surg Pak 2005; 15: 624-7.
6. Moodley J, Moodey V V. Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy - The need for a large randomized trial. Hyper Pregnancy 1994; 13: 245-52.
7. Coetzee E, Dommisse J, Anthony J. A randomized control trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300-3.
8. Odendaal HJ, Hall DR. Is magnesium sulphate prophylaxis necessary in pre-eclampsia? Outcome of infants delivered between 24 and 28 weeks' gestation in women with severe pre-eclampsia. J Maternal Fetal Invest 1996; 6: 14-8.
9. Hiett AK, Brown HL, Britton KA. Outcome of infants delivered between 24 and 28 weeks' gestation in women with severe pre-eclampsia. Fetal Med 2001; 10: 301-4.
10. Hall DR, Odendal HJ, Smith MI. Prophylactic administration of magnesium sulphate is indicated prior to labour? Br J Obstet Gynaecol 2000; 107: 903-8.
11. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951-63.
12. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.
13. WHO International Collaborative Study of hypertensive disorders of pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1998; 158: 80-3.
14. Baha, Sibai MD, Brianet AL. Aggressive versus expectant management of severe pre-eclampsia at 28-32 weeks gestation: a randomized control trial. Am J Obstet Gynecol 1994; 171: 818.
15. Belfort MA, Anthony J, Saade GR, Allen JC. A comparison of magnesium sulphate and nimodipine for prevention of eclampsia. N Engl Med 2003; 348: 304-11.
16. Zuspan FP, Ward MC. Improved fetal salvage in eclampsia. Obstet Gynecol 1965; 26: 893-7.
17. Begum MR, Begum A, Quadir E. Loading dose versus standard regime of magnesium sulphate in the management of eclampsia: a randomized trial: J Obstet Gynaecol Res 2002; 28: 154-9.
18. Noor S, Halimi M, Ruby N, Gull F, Akbar N. Magnesium sulphate in the prophylaxis and treatment of eclampsia. J Ayub Med Coll Abottabad 2004; 16: 50-4.
19. Sibai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163: 1049-55.
20. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951-63.
21. Usta IM, Sibai BM. Emergent management of puerperal eclampsia. Obstet Gynecol Clin N Am 1995; 22: 315-333.
22. Lu JF, Nightingle CH. Magnesium sulphate in eclampsia and pre-eclampsia. Clin Pharmacokinet 2000; 38: 305-314.
23. Gofton EN, Capewell V, Natale R, Gratton RJ. Obstetrical intervention rates and maternal and neonatal outcomes of women with gestational hypertension. Am J Obstet Gynecol 2001; 185: 798-803.
24. Magpie Trial Follow-Up Study Management Group. The Magpie trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia. BMC Pregnancy Childbirth 2004; 4.
25. Magpie Trial Follow Up Study Collaborative Group. The Magpie trial: a randomized trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG 2007; 114: 300-9.